Trial Profile
In 4 year old children, does having received a birth dose of acellular pertussis vaccine compared to not having received a birth dose of acellular pertussis vaccine affect immunogenicity and safety before and after a booster dose of an acellular pertussis vaccine.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine
- Indications Pertussis
- Focus Pharmacodynamics
- 01 May 2022 According to a Form 6-K, 2022, company SEC filing, GlaxoSmithKline has changed its name to GSK.
- 19 Dec 2014 New trial record